January 30, 2018 / 7:35 AM / 7 months ago

BRIEF-Celon Pharma Signs Deal For Industrial Development And Production For Clinical Trial Of Anti-VEGF Protein

Jan 30 (Reuters) - Celon Pharma SA:

* SIGNS CONTRACT WITH BIOTECHPHARMA FOR INDUSTRIAL DEVELOPMENT AND PRODUCTION FOR CLINICAL TRIAL IN GMP QUALITY OF ANTI-VEGF PROTEIN

* VALUE OF CONTRACT WITH BIOTECHPHARMA IS ABOUT 2-3 MILLION EUROS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below